Oaktree Acquisition Corp. III Life Sciences (OACCU) Net Cash Flow (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Net Cash Flow came in at -$158035.0 in Q1 2026, down 109.15% YoY from $1.7 million in Q1 2025, and down 248.92% on a QoQ basis from $106124.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Net Cash Flow (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of Net Cash Flow data on file, last reported at -$158035.0 in Q1 2026.
- Quarterly Net Cash Flow fell 109.15% year-over-year to -$158035.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$254553.0 (changed N/A YoY) and the FY2025 annual result came in at $77921.0, down 94.26% from the prior year.
- Net Cash Flow declined to -$158035.0 in Q1 2026, from $106124.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $106124.0 in Q4 2025 to a low of -$158035.0 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -97,260.00 |
| Jun 30, 2026 | -97,260.00 |
| Mar 31, 2026 | -158,035.00 |
| Mar 31, 2026 | -158,035.00 |
| Dec 31, 2025 | 106,124.00 |
| Dec 31, 2025 | 106,124.00 |
| Sep 30, 2025 | -56,518.00 |
| Sep 30, 2025 | -56,518.00 |
| Jun 30, 2025 | -146,124.00 |
| Jun 30, 2025 | -146,124.00 |
| Mar 31, 2025 | -75,561.00 |
| Mar 31, 2025 | -75,561.00 |